MENU
+Compare
GSK
Stock ticker: NYSE
AS OF
Sep 24, 04:59 PM (EDT)
Price
$40.20
Change
-$0.32 (-0.79%)
Capitalization
81.88B

GSK GSK plc Forecast, Technical & Fundamental Analysis

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales... Show more

GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GSK with price predictions
Sep 23, 2025

GSK's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for GSK moved out of overbought territory on August 25, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 instances where the indicator moved out of the overbought zone. In of the 41 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where GSK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GSK as a result. In of 66 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GSK turned negative on September 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GSK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GSK broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The 10-day moving average for GSK crossed bullishly above the 50-day moving average on August 19, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GSK advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 244 cases where GSK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.095) is normal, around the industry mean (9.505). P/E Ratio (18.196) is within average values for comparable stocks, (23.728). Projected Growth (PEG Ratio) (0.354) is also within normal values, averaging (1.818). Dividend Yield (0.041) settles around the average of (0.028) among similar stocks. P/S Ratio (1.972) is also within normal values, averaging (3.454).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GSK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

View a ticker or compare two or three
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GSK is expected to report earnings to rise 163.83% to $1.24 per share on October 29

GSK plc GSK Stock Earnings Reports
Q3'25
Est.
$1.24
Q2'25
Missed
by $0.71
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.14
The last earnings report on July 30 showed earnings per share of 46 cents, missing the estimate of $1.18. With 1.41M shares outstanding, the current market capitalization sits at 81.88B.
A.I.Advisor
published Dividends

GSK is expected to pay dividends on October 09, 2025

GSK plc GSK Stock Dividends
A dividend of $0.43 per share will be paid with a record date of October 09, 2025, and an ex-dividend date of August 15, 2025. The last dividend of $0.43 was paid on July 10. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and other pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
980 Great West Road
Phone
+44 2080475000
Employees
70212
Web
https://www.gsk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PXI46.550.84
+1.83%
Invesco Dorsey Wright Energy MomentumETF
NPV11.590.08
+0.70%
Nuveen Virginia Quality Municipal Income Fund
GJR24.77N/A
N/A
Synthetic Fixed Income Securities
FYX109.89-0.21
-0.19%
First Trust Small Cap Core AlphaDEX® ETF
VUG478.98-5.10
-1.05%
Vanguard Growth ETF

GSK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with AZN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-0.95%
AZN - GSK
62%
Loosely correlated
-1.97%
PFE - GSK
57%
Loosely correlated
+0.37%
SNY - GSK
53%
Loosely correlated
-0.28%
JNJ - GSK
50%
Loosely correlated
+1.36%
MRK - GSK
46%
Loosely correlated
-0.55%
More

Groups containing GSK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-0.95%
GSK
(2 stocks)
83%
Closely correlated
-0.32%